Publication

Abstract : The private sector accounts for more than half of the tuberculosis (TB) care delivered in India, with major challenges in the quality of diagnosis and treatment.1–3 The indiscriminate use of anti-tuberculosis drugs outside the Revised National TB Control Programme (RNTCP) is an important factor fuelling the emergence of drug-resistant TB.4 Our hospital is a private tertiary care centre with an annual patient turnover of 800 000 out-patients and 50 000 in-patients. The hospital's Anti-Tuberculosis Treatment Stewardship (ATTS) is modelled on the already existing robust multidisciplinary antimicrobial stewardship programme, which has been conducting detailed daily audits of restricted antibiotic prescriptions and recommending changes to ensure appropriate prescribing.